Rinvoq – Compliance Alert

65

Caution

Rinvoq scores 65/100 (Caution) based on analysis of 60s promotional content. 4 enforcement patterns detected across Visual Distraction, Fair Balance — “Outdoor & Physical Activity” identified at 13.1s, previously cited in BRUKINSA, COBENFY, Fasenra (x3). Weakest dimension: Visual Distraction at 38/100.

Rinvoq | AbbVie | DTC Broadcast

Mar 7, 2026

Patterns Detected (4)

Matched against 14 enforcement patterns from 42 FDA letters

Visual Distraction

Outdoor & Physical Activity

Risk information must be presented in a clear, conspicuous, and neutral manner without distracting visuals

38

13.1s – 31.4s

31.5s – 38.0s

38.0s – 43.5s

Visual Distraction

Family & Social Scenes

Risk information must be presented in a clear, conspicuous, and neutral manner without distracting visuals

38

38.0s – 43.5s

49.0s – 54.6s

Visual Distraction

Daily Activities

Risk information must be presented in a clear, conspicuous, and neutral manner without distracting visuals

38

13.1s – 31.4s

43.6s – 49.0s

Fair Balance

Benefit vs. Risk Time Imbalance

Risk and benefit information must be presented with equal prominence

73

1.73:1

Benefit:Risk Ratio

65

Master

Safety Information Window

Risk disclosure: 31.4s – 53.4s (22.1s of 60.1s total — 36.7% of ad)

13.1s — Daily Activities+Vd Outdoor Physical

31.5s — Outdoor Physical

38.0s — Family Social+Vd Outdoor Physical

43.6s — Daily Activities

49.0s — Family Social

0s60s

Visual Evidence (5 clips)

13.1s – 31.4s Daily Activities, Outdoor Physical

31.5s – 38.0s Outdoor Physical

38.0s – 43.5s Family Social, Outdoor Physical

43.6s – 49.0s Daily Activities

49.0s – 54.6s Family Social

Recommendations

high

Flag for next MLR cycle: Visual content during safety information window (31s–53s) may distract from risk disclosure. Schedule creative revision to use static or neutral visuals during major statement.

Compliance Alert: Rinvoq

Patterns Detected (4)

Visual Evidence (5 clips)

Recommendations